Research
Education
Solutions
Sign In
EN
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
TR - Turkish
JA - Japanese
Antibacterial Discovery Performance Unit
Jennifer L. Hoover has not added Biography.
If you are Jennifer L. Hoover and would like to personalize this page please email our Author Liaison for assistance.
Novel hydroxyl tricyclics (e.g., GSK966587) as potent inhibitors of bacterial type IIA topoisomerases.
Bioorganic & medicinal chemistry letters Oct, 2013 | Pubmed ID: 23968823
Novel tricyclics (e.g., GSK945237) as potent inhibitors of bacterial type IIA topoisomerases.
Bioorganic & medicinal chemistry letters May, 2016 | Pubmed ID: 27055939
Pharmacokinetic-Pharmacodynamic Evaluation of Gepotidacin Against Gram-Positive Organisms Using Data From Murine Infection Models.
Antimicrobial agents and chemotherapy Nov, 2016 | Pubmed ID: 27872075
GlaxoSmithKline
Jennifer L. Hoover1,
Thomas F. Lewandowski1,
Cindy L. Mininger1,
Christine M. Singley1,
Scott Sucoloski1,
Stephen Rittenhouse1
1Antibacterial Discovery Performance Unit, GlaxoSmithKline
Privacy
Terms of Use
Policies
Contact Us
Recommend to library
JoVE NEWSLETTERS
JoVE Journal
Methods Collections
JoVE Encyclopedia of Experiments
Archive
JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
Faculty Resource Center
Authors
Librarians
Access
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved